Ratings Genetec Technology

Equities

GENETEC

MYQ0104OO008

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.91 ^MYR	+0.53%		+3.24%	-19.07%

Feb. 27	Genetec Technology Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Genetec Technology's Profit Drops in September Quarter	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's activity appears highly profitable thanks to its outperforming net margins.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

The company's enterprise value to sales, at 3.52 times its current sales, is high.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

Ratings chart - Surperformance

Sector: Industrial Machinery & Equipment

	1st Jan change	Capi.	ESG Refinitiv
GENETEC TECHNOLOGY	-19.07%	311M	-
ATLAS COPCO AB	+11.73%	82.35B	A-
PARKER-HANNIFIN CORPORATION	+20.17%	71.09B	B
INGERSOLL RAND INC.	+20.89%	37.72B	B-
XYLEM INC.	+15.77%	32.01B	A
FANUC CORPORATION	+9.19%	27.2B	B-
FORTIVE CORPORATION	+3.18%	26.74B	C+
SANDVIK AB	+4.22%	26B	B+
TECHTRONIC INDUSTRIES CO. LTD.	+16.93%	25.5B	B+
DOVER CORPORATION	+17.14%	24.76B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes